E. Ohman J or Asset Management AB Buys 119,605 Shares of Stryker Corporation $SYK

E. Ohman J or Asset Management AB increased its stake in Stryker Corporation (NYSE:SYK) by 1,008.0% during the second quarter, Holdings Channel.com reports. The fund owned 131,471 shares of the medical technology company’s stock after buying an additional 119,605 shares during the period. Stryker makes up about 1.0% of E. Ohman J or Asset Management AB’s portfolio, making the stock its 21st biggest position. E. Ohman J or Asset Management AB’s holdings in Stryker were worth $41,392,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Brighton Jones LLC increased its position in shares of Stryker by 15.4% during the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after buying an additional 609 shares during the period. Schnieders Capital Management LLC. acquired a new position in Stryker in the second quarter valued at $205,000. Marshall Wace LLP lifted its holdings in Stryker by 107.9% in the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock valued at $2,255,000 after buying an additional 77,831 shares during the period. Nebula Research & Development LLC bought a new stake in Stryker during the second quarter valued at $219,000. Finally, HUB Investment Partners LLC bought a new stake in Stryker during the second quarter valued at $253,000. 77.09% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total value of $96,791,300.00. Following the completion of the sale, the director owned 1,924,880 shares of the company’s stock, valued at approximately $601,005,282.40. This trade represents a 13.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Robert S. Fletcher sold 4,544 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president owned 10,582 shares of the company’s stock, valued at $3,247,298.34. This trade represents a 30.04% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on SYK. Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a research report on Saturday. Wolfe Research set a $375.00 target price on Stryker in a research report on Friday, July 31st. Citigroup restated an “outperform” rating on shares of Stryker in a research report on Monday, August 3rd. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $361.00 target price on shares of Stryker in a research note on Friday, May 1st. Finally, Argus set a $370.00 target price on Stryker in a report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $386.28.

Stryker Stock Performance

Shares of Stryker stock opened at $345.05 on Tuesday. The business has a 50-day simple moving average of $321.03 and a 200 day simple moving average of $333.81. Stryker Corporation has a one year low of $281.00 and a one year high of $396.86. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The firm has a market capitalization of $132.35 billion, a price-to-earnings ratio of 35.76, a PEG ratio of 2.16 and a beta of 0.76.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. During the same quarter in the prior year, the company earned $3.13 earnings per share. The company’s quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, research analysts anticipate that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Wednesday, September 30th. Stryker’s dividend payout ratio (DPR) is currently 36.48%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.